Executive ManagementRichard Allen
Mr. Allen co-founded RTI Biologics (Nasdaq:RTIX), a medical device company with proprietary technology in orthopedics and tissue regeneration, and led the company's IPO in August 2000. In addition to RTIX, he has co-founded several successful medical technology companies, including Axogen (Nasdaq:AXGN)(peripheral nerve regeneration), ViewRay (beam-on MRI-guided radiation therapy devices), OrthoHelix (small bone orthopedics), Optima Neuroscience (neural monitoring technology), RegisterPatient.com (cloud-based patient registration), and HyGreen (a spinoff company from Xhale that markets a novel electronic hand hygiene monitoring and reminding system). Mr. Allen also co-founded Synogen, a private equity medical technology venture fund, and Emergent Growth Fund, a technology investment fund. He is a CPA and has served on the boards of numerous companies.
Ronald E. Youngblood II, B.S.
Executive Vice President of Operations
Mr. Youngblood is a graduate of the University of Florida, with a degree in Resource Economics. He has over 25 years of manufacturing experience, spanning all aspects from planning and hands-on development to managing processes and associates. Mr. Youngblood spent 14 years with Honeywell International, primarily with Honeywell’s Guidance and Navigation Operations center in Clearwater, Florida. There, he was responsible for development and manufacture of inertial guidance systems with embedded GPS capability that are currently in use on a multitude of aircraft and missiles worldwide. While at Honeywell, Mr. Youngblood was trained and certified as an expert in Demand Flow and Lean Manufacturing, and completed extensive specialized training in Root Cause and Corrective Action processes.
In 1998, Mr. Youngblood joined the startup company Regeneration Technologies, Inc. in Alachua, Florida and became Manager of Spinal Allograft Manufacturing, reporting directly to the Vice President of Operations. In 2000 Mr. Youngblood supported a successful IPO that helped position RTI as a world leader in the biomedical industry. During his tenure, he managed all aspects of biomedical manufacturing in both human and bovine production from initial concept through product launch utilizing state of the art machining, a highly skilled staff and the trademarked Biocleanse sterilization process.
In 2006, Mr. Youngblood joined the startup company Xhale Inc. in Gainesville, Florida and became Vice President of Operations reporting directly to the CEO. Mr. Youngblood has been instrumental in the product development and commercialization of both Xhale Inc. and HyGreen lines and oversees all Engineering , Manufacturing and Installation activities on a national level.
Richard J. Melker, M.D., Ph.D.
Chief Technology Officer
Dr. Melker, co-founder and Chief Technology Officer with Xhale, received his Ph.D. (Neurobiology) and M.D. degrees from Albert Einstein College of Medicine. After a residency in Pediatrics, and fellowships in Pediatric Cardiology and Critical Care Medicine, he served as Director of Emergency Services at Shands Hospital at the University of Florida College of Medicine, as well as Medical Liaison for the NASA space shuttle program. He holds the position of Professor of Anesthesiology, Pediatrics and Biomedical Engineering at U.F. and since 1993 has been Director of the Florida Anesthesiology Computer and Engineering Team (FACET) which develops and licenses medical devices and technologies. Dr. Melker holds over 35 issued U.S. patents including several for emergency medical devices in use throughout the world, and by the U.S. Special Forces.
Elena Fraser, MBA
Vice President of Sales and Marketing
Elena Fraser is the Vice President of Sales and Marketing for HyGreen. In her role, she is responsible for leading and growing HyGreen through sales and sales management, distribution partnerships, integrated marketing and brand strategy.
Ms. Fraser has 15+ years of executive leadership in the medical technology industry and has a wide array of expertise across many disciplines including sales management, marketing, product development, global product distribution and support, financing and general business & strategic development efforts.
Ms. Fraser holds an MBA from Northwestern University.